The UK PARA and the US PANCE are both gateway exams for physician associate/assistant practice — but they are different exams testing different content against different clinical standards. Understanding the differences matters if you are a US PA considering UK practice, a UK PA curious about the US system, or a PA student deciding where to build your career.
Format Comparison
PARA (UK): Two separate components — KBA (200-item MCQ) + OSCE (14 clinical stations). Both must be passed. Components can be taken in either order. Total cost: £920. Administered by the RCP on behalf of the GMC.
PANCE (US): A single 300-question computer-based exam (five blocks of 60 questions). No OSCE component. Cost: $550 (approximately £440). Administered by the NCCPA (National Commission on Certification of Physician Assistants).
The PARA's inclusion of an OSCE component is a significant structural difference. UK regulation explicitly tests clinical skills, communication, and professional behaviour in simulated patient encounters — reflecting the UK healthcare system's emphasis on consultation quality alongside clinical knowledge. The PANCE tests knowledge only, relying on clinical training programmes and post-qualification supervision to ensure clinical competence.
Content and Clinical Standards
PARA: Aligned to the 2023 UK Physician Associate Curriculum. Management pathways follow NICE guidelines. Prescribing references the BNF. The clinical context assumes NHS practice — primary care, hospital medicine, emergency departments, and community settings within the UK healthcare system. Currently, UK PAs cannot prescribe independently (this is under review).
PANCE: Aligned to the NCCPA content blueprint. Management follows US clinical guidelines (USPSTF, ACC/AHA, ADA, etc.). Prescribing references US formularies. US PAs have prescribing authority (varies by state) and may practise with varying degrees of supervision depending on state law.
The clinical knowledge overlaps substantially — medicine is medicine, and the core conditions tested are similar. The differences are in the specific management recommendations (NICE vs US guidelines), the pharmacology (UK drug names vs US names, different formularies), and the professional practice framework (GMC regulation vs state-by-state US regulation).
Regulatory Framework
UK: Statutory GMC regulation from December 2024, mandatory from December 2026. Single national standard. Recertification required every six years.
US: NCCPA certification. Recertification every 10 years (PANRE). State-level licensing with varying scope of practice laws, prescribing authority, and supervision requirements.
The UK system is more centralised and prescriptive. The US system is more varied and state-dependent.
Cross-Recognition
A US PANCE pass is not accepted for UK GMC registration if you were never on the FPA's Managed Voluntary Register. You must sit the PARA. The clinical content is similar, but the UK guideline alignment, the OSCE component, and the regulatory framework require UK-specific assessment.
If you are a US PA preparing for the PARA, iatroX provides the UK-specific clinical knowledge layer — free adaptive preparation grounded in NICE, CKS, and BNF. Ask iatroX translates your US clinical knowledge into UK-guideline-aligned practice instantly. The clinical reasoning is the same; the specific answers differ by jurisdiction.